Ankyrin repeat domain 33B pseudogene 1 (ANKRD33BP1)

ANKRD33BP1, or Ankyrin repeat domain 33B pseudogene 1, is classified as a pseudogene—a segment of DNA related to the functional ANKRD33B gene but which is not believed to encode a functional protein[3]. Pseudogenes generally do not function as receptors, enzymes, or therapeutic targets. In general, pseudogenes can act as regulatory non-coding RNAs (ceRNAs) and play roles in modulating gene expression, but there is no published evidence for a therapeutic or biomarker role for ANKRD33BP1 specifically[2][3]. ANKRD33B, the related protein-coding gene, itself contains ankyrin repeat domains (protein–protein interaction motifs) and has been implicated in cancer progression and developmental regulation; however, these functions have not been attributed to the pseudogene ANKRD33BP1[1]. There are no known drugs, disease mutations, or established mechanism of action documented for ANKRD33BP1, and it is not considered a therapeutic target by current resources[3]. Note: This query appears to target a pseudogene, not a functional therapeutic target like a receptor, enzyme, transporter, or transcription factor[3]. It is important to distinguish between ANKRD33BP1 (pseudogene) and ANKRD33B (the protein-coding gene). Any suggestion of biological function, disease association, or therapeutic use relates to the protein-coding gene, not the pseudogene[1][3].

Other names

ANKRD33B pseudogene 1ANKRD33BP1ankyrin repeat domain 33B pseudogeneANKRD33B Pseudogene 1